Your browser doesn't support javascript.
loading
Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program.
Rebuzzi, S E; Signori, A; Buti, S; Banna, G L; Murianni, V; Damassi, A; Maruzzo, M; Giannarelli, D; Tortora, G; Galli, L; Rizzo, M; De Giorgi, U; Antonuzzo, L; Bracarda, S; Cartenì, G; Atzori, F; Tamberi, S; Procopio, G; Fratino, L; Lo Re, G; Santoni, M; Baldessari, C; Astone, A; Calabrò, F; Brunelli, M; Porta, C; Rescigno, P; Basso, U; Fornarini, G.
Affiliation
  • Rebuzzi SE; Medical Oncology Unit, San Paolo General Hospital, Savona; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova.
  • Signori A; Health Sciences, Section of Biostatistics, University of Genova, Genova.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Banna GL; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK. Electronic address: giuseppe.banna@ircc.it.
  • Murianni V; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova.
  • Damassi A; Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino, Genova.
  • Maruzzo M; Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padova.
  • Giannarelli D; Department of Biostatistics, IRCCS Regina Elena National Cancer Institute, Rome.
  • Tortora G; Medical Oncology, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome; Medical Oncology, Università Cattolica del Sacro Cuore, Rome.
  • Galli L; Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa.
  • Rizzo M; Division of Translational Oncology, IRCCS Istituti Clinici Scientifici Maugeri, Pavia.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola.
  • Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence; Department of Experimental and Clinical Medicine, University of Florence, Florence.
  • Bracarda S; Medical and Translational Oncology, Department of Oncology, Azienda Ospedaliera Santa Maria, Terni.
  • Cartenì G; Division of Oncology, Azienda Ospedaliera di Rilievo Nazionale A. Cardarelli, Napoli.
  • Atzori F; Medical Oncology Department, University Hospital, University of Cagliari, Cagliari.
  • Tamberi S; Oncology Unit, Ospedale 'degli Infermi', Faenza.
  • Procopio G; SS Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
  • Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano CRO-IRCCS, Aviano.
  • Lo Re G; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano CRO-IRCCS, Aviano.
  • Santoni M; Oncology Unit, Macerata Hospital, Macerata.
  • Baldessari C; Department of Oncology and Hematology, University Hospital of Modena, Modena.
  • Astone A; Division of Medical Oncology, Fatebenefratelli San Pietro Hospital, Rome.
  • Calabrò F; Division of Medical Oncology, San Camillo Forlanini Hospital, Rome.
  • Brunelli M; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona.
  • Porta C; Interdisciplinary Department of Medicine, University of Bari 'A. Moro', Bari; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Rescigno P; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
  • Basso U; Oncology Unit 1, Istituto Oncologico Veneto IOV-IRCCS, Padova.
  • Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova.
ESMO Open ; 7(6): 100634, 2022 12.
Article in En | MEDLINE | ID: mdl-36493602
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article